Veracyte | VCYT - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Agenus USD -199.08M 22.15M 2026-06
Agilent USD 1.43B 2M 2026-06
Anika Therapeutics USD 137.28M 3.38M 2026-06
Arrowhead Research USD 245.35M 30.35M 2026-06
Bruker USD 768.9M 44.3M 2026-06
Heron Therapeutics USD 40.55M 1.46M 2025-12
Illumina USD 899M 47M 2026-06
Intrexon USD 61.56M 26.1M 2024-06
Karyopharm Therapeutics USD 61.83M 9.9M 2026-03
Laboratory Of America USD 3.27B 146.9M 2026-06
Ligand Pharmaceuticals USD 55.1M 20.75M 2026-06
Myriad Genetics USD 212.8M 16.2M 2025-12
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Siemens EUR 17.6B 531M 2026-06
Sonic Healthcare AUD 4.23B 2.14B 2024-12
Thermo Fisher Scientific USD 9.81B 716M 2026-06
Veracyte USD 126.36M 6.37M 2026-06
Waters USD 527M 592M 2026-06